Fig. 1
From: Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study
a Overall survival among patients with acute GVHD. b Overall survival in responders vs non-responder acute GVHD patients
Fig. 1 | Bone Marrow Transplantation
